PS Ratio Chart

View PS Ratio for ADRMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2026. Start Trial.
Date Value
August 25, 2026 0.0675
August 24, 2026 0.0675
August 21, 2026 0.0675
August 20, 2026 0.0675
July 27, 2026 0.0675
July 24, 2026 0.0675
July 23, 2026 0.0675
July 22, 2026 0.0675
July 21, 2026 0.0675
July 20, 2026 0.0675
July 17, 2026 0.0675
July 16, 2026 0.0675
July 15, 2026 0.0675
Date Value
July 14, 2026 0.0675
July 13, 2026 0.0675
July 10, 2026 0.0675
July 09, 2026 0.0675
July 08, 2026 0.0675
July 07, 2026 0.0675
July 06, 2026 0.0675
June 29, 2026 0.0675
June 26, 2026 6.752
June 25, 2026 6.752
June 24, 2026 6.752
June 23, 2026 6.752

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Cochlear Ltd. 4.086
ImpediMed Ltd. 0.8843
Biotricity, Inc. 0.1857
Nanosonics Ltd. 5.144
Somnomed Ltd. 1.268

PS Ratio Related Metrics

Price 0.003
Earnings Yield -21.49K%
Market Cap 0.1095M